August 30, 2010
GSK and Valeant announce new U.S. FDA PDUFA goal date for ezogabine
August 23, 2010
GSK commences Phase III clinical trials to develop herpes zoster vaccine for the prevention of shingles
August 11, 2010
Ezogabine, an investigational anti-epileptic drug, receives positive vote from FDA advisory committee
August 05, 2010
Image of new antibiotic in action opens up new opportunities to combat antibacterial resistance
July 30, 2010
GlaxoSmithKline begins distribution of flu vaccine to U.S. customers for 2010-2011 flu season
July 29, 2010
GSK exercises option on Anacor’s novel antibiotic for the treatment of gram-negative infections
July 26, 2010
GlaxoSmithKline to Implement New Compensation Program for U.S. Sales Professionals
July 21, 2010
GlaxoSmithKline statement in response to FDA announcement on TIDE trial
July 21, 2010
GSK announces Q2 results for 2010
July 16, 2010
Update to 2009 Notification of Stolen Advair Diskus Inhalers
July 16, 2010
Stiefel, a GSK company, Receives FDA Approval of VELTIN™ (clindamycin phosphate and tretinoin) Gel 1.2%/0.025%
July 15, 2010
GlaxoSmithKline legal update
July 14, 2010
GlaxoSmithKline statement in response to FDA Advisory Committees’ vote on safety of Avandia® (rosiglitazone)
July 14, 2010
Information Notice on Certain Stolen Consumer Health Products from GlaxoSmithKline
July 13, 2010
GlaxoSmithKline (GSK) responds to Senate Finance Committee letter of 12 July to FDA
July 09, 2010
Data support Avandia (rosiglitazone maleate) cardiovascular safety profile
July 01, 2010
BC and Goody’s online “Pick A Powder” contest kicks off starring Trace Adkins and Richard Petty
July 01, 2010
GSK and Aptuit finalise agreement for Aptuit to acquire GSK’s research operations in Italy
June 23, 2010
GlaxoSmithKline enters agreement with Medivir for exclusive rights to cold sore treatment Xerclear™
June 18, 2010
FDA approves STAXYN™ (vardenafil HCl) orally disintegrating tablets for erectile dysfunction (ED)
June 11, 2010
GlaxoSmithKline Receives Complete Response from FDA for Candidate Meningococcal and Hib Combination Vaccine
June 10, 2010
GSK drives Latin America growth strategy with acquisition of Laboratorios Phoenix
June 10, 2010
Regulatory update – BLA filed for Benlysta® (belimumab)
June 02, 2010
GSK announces revised product labels for Serevent and Advair
May 26, 2010
GSK Consumer Healthcare to update alli label as FDA completes safety review of orlistat
May 19, 2010
New research identifies promising leads to follow in search for medicines to fight malaria
May 14, 2010
FDA says Healthcare Providers can resume use of Rotarix (Rotavirus Vaccine, Live, Oral)
May 11, 2010
Patrick Vallance appointed to GSK executive leadership team
May 11, 2010
GSK extends presence in Asia with new strategic alliance in South Korea
May 07, 2010
GSK Statement on FDA Advisory Committee Meeting on Rotavirus Vaccines
May 04, 2010
New survey shows families may not be addressing their oral health care needs
April 28, 2010
GSK announces Q1 results for 2010
April 27, 2010
New Nicorette mini lozenge offers convenient, pocket-sized support to help smokers looking to quit
April 13, 2010
GlaxoSmithKline honors healthcare nonprofits with $360,000 in awards
March 31, 2010
GSK and Isis Pharmaceuticals collaborate on RNA therapeutics for rare and infectious diseases
March 29, 2010
GSK regulatory update – Avodart (dutasteride)
March 29, 2010
GSK offers free vaccines to uninsured adults
March 26, 2010
Updated GlaxoSmithKline statement on European regulatory guidance relating to manufacture of Rotarix (rotavirus vaccine)
March 23, 2010
GSK responds to JAMA editorial and commentary
March 22, 2010
GlaxoSmithKline statement on new information relating to manufacture of Rotarix (rotavirus vaccine)
March 22, 2010
GSK announces succession plan for leadership of Consumer Healthcare business
March 19, 2010
GlaxoSmithKline commences Relovair Phase III asthma programme
March 16, 2010
GSK publishes 2009 Corporate Responsibility Report
March 15, 2010
Reminder: GlaxoSmithKline 14th Annual IMPACT awards application deadline March 29, 2010
March 12, 2010
GSK commences succession plan for management of vaccines business
March 08, 2010
GSK CEO Andrew Witty dedicates albendazole facility in Nashik to WHO’s Global Programme to Eliminate LF
February 24, 2010
GlaxoSmithKline responds to US Senate Committee on Finance report on Avandia
February 24, 2010
Information notice on certain stolen pharmaceutical and consumer health products from GlaxoSmithKline
February 20, 2010
GSK rejects conclusions of Senate Committee on Finance Staff Report on Avandia
February 20, 2010
GSK rejects conclusions reported in The New York Times story on Avandia
February 18, 2010
GSK statement on FDA’s proposed label revisions for some asthma medicines
February 18, 2010
GSK Consumer Healthcare warns consumers of potential health risks associated with long-term excessive use of zinc-containing denture adhesives
February 17, 2010
GlaxoSmithKline and XenoPort receive FDA Complete Response letter for Horizant™ (GSK1838262/XP13512) for RLS
February 15, 2010
GlaxoSmithKline 14th Annual IMPACT Awards seek Greater Philadelphia and Camden healthcare nonprofits
February 10, 2010
GlaxoSmithKline introduces CARES by GSK to improve patient access to GSK oncology and specialty medicines
February 04, 2010
GSK launches new specialist unit to research and develop medicines for rare diseases
February 04, 2010
GSK announces appointment of Philippe Fauchet as President of GSK Japan
February 04, 2010
Results announcement for the fourth quarter 2009
February 02, 2010
Make the big game healthy and heartburn free
January 29, 2010
GSK’s TYKERB receives accelerated approval for first-line combination treatment of metastatic breast cancer
January 29, 2010
FDA approves once-a-day LamictalXR as add-on epilepsy therapy for primary generalized tonic-clonic seizures
January 26, 2010
GlaxoSmithKline grants $360,000 to nine healthcare nonprofits – each to receive $40,000
January 20, 2010
GSK announces ‘open innovation’ strategy to help deliver new and better medicines for people living in the world’s poorest countries
January 18, 2010
GSK contributes to Haiti relief efforts
January 15, 2010
GlaxoSmithKline update: Government orders for pandemic H1N1 vaccine
January 13, 2010
Eight in 10 Americans say they’re in control of their eating habits – but growing obesity crisis tells another story
January 12, 2010
GlaxoSmithKline update: Government orders for pandemic H1N1 vaccine
December 16, 2009
GlaxoSmithKline and NanoBio announce OTC licensing agreement for cold sore treatment
December 14, 2009
GSK publishes speaking, consulting fees paid to US healthcare professionals
December 11, 2009
GSK study showed targeted therapy combination achieved 14 month overall survival in patients with advanced breast cancer
December 11, 2009
GSK and Intercell form strategic alliance to develop and commercialise innovative needle-free patch-based vaccines
December 09, 2009
GSK initiates second pivotal Phase III trial for investigational cardiovascular medication Darapladib
December 08, 2009
Long-term Bexxar® data demonstrate overall survival
December 08, 2009
Stop-smoking gum launches new campaign showing smokers how quitting can “Suck Less”
December 01, 2009
GSK Update: GSK’s Arepanrix™ H1N1 pandemic vaccine prequalified by the World Health Organization
December 01, 2009
GSK completes extension of strategic collaboration with Aspen
November 30, 2009
GlaxoSmithKline establishes $1 million scholarship fund at The Philadelphia Foundation
November 30, 2009
GlaxoSmithKline announced as Tier 3 Sponsor as London 2012 anti-doping plans confirmed
November 30, 2009
Regulatory Update: GSK files Rotarix for prevention of rotavirus in Japan
November 24, 2009
GlaxoSmithKline and Gilead announce agreement to commercialise Viread® for chronic hepatitis B in key Asian countries
November 23, 2009
GSK Regulatory Update: Avodart
November 23, 2009
Pandemic 2009 Influenza Update: Pandemrix™ data in children and adolescents from 3 to 17 years of age
November 16, 2009
GSK and Nabi announce agreement for NicVAX®, a vaccine for nicotine addiction
November 10, 2009
Pandemic 2009 Influenza Update: US FDA approves GSK’s pandemic H1N1 vaccine
November 10, 2009
GSK signs agreement with the WHO to donate 50 million doses of pandemic H1N1 vaccine for distribution to developing countries
November 09, 2009
GlaxoSmithKline and XenoPort announce extension of GSK1838262 (XP13512) FDA review date to 9 February, 2010
November 09, 2009
Pandemic 2009 Influenza Update: Pandemrix™ data on co-administration with annual seasonal influenza vaccine (Fluarix®)
November 06, 2009
World Health Organization Grants Prequalification for Global Use to GSK’s 10-Valent Synflorix™ Vaccine
November 05, 2009
Nine area healthcare nonprofits win $40,000 each in funding from GlaxoSmithKline in partnership with the Triangle Community Foundation
November 03, 2009
World’s largest malaria vaccine trial now underway in seven African countries
November 03, 2009
ViiV Healthcare launches: A new specialist HIV company dedicated to delivering advances in HIV treatment and care
November 02, 2009
Retigabine Regulatory Update
November 02, 2009
GlaxoSmithKline and Human Genome Sciences announce positive results in second of two phase 3 trials of Benlysta in systemic lupus erythematosus
October 28, 2009
Results announcement for the third quarter 2009
October 27, 2009
Pandemic 2009 Influenza Update: Pandemrix™ data in an elderly population
October 27, 2009
GlaxoSmithKline and Theravance commence Phase III Horizon programme to develop a next-generation treatment for COPD
October 26, 2009
GSK and Genmab receive accelerated approval for Arzerra™
October 23, 2009
Pandemic (H1N1) 2009 Influenza Update: Experience of GSK’s H1N1 adjuvanted vaccine, Pandemrix™, and preliminary paediatric results
October 21, 2009
CDC Advisory Committee recommends Cervarix to prevent cervical cancer in girls and young women
October 19, 2009
FDA approves GlaxoSmithKline’s Votrient™ for advanced renal cell cancer
October 16, 2009
FDA approves Cervarix, GlaxoSmithKline’s cervical cancer vaccine
October 16, 2009
GSK’s Cervarix® becomes the first cervical cancer vaccine to gain approval in Japan
October 13, 2009
GSK Statement on Jury Verdict in Paxil Product Liability Trial in Philadelphia Court of Common Pleas
October 13, 2009
GlaxoSmithKline and Prosensa form alliance to fight Duchenne Muscular Dystrophy
October 13, 2009
GSK partners with UK Government and Wellcome Trust to stimulate innovation through the creation of a world-class science park
October 12, 2009
GSK’s Avodart® / tamsulosin combination showed benefits for men with prostate enlargement
October 08, 2009
GlaxoSmithKline and U.S. Patent and Trademark Office file a motion to dismiss litigation over Final Regulations
October 06, 2009
GSK expands presence in China through strategic cooperation to form a joint venture on paediatric vaccines
October 06, 2009
GlaxoSmithKline update: Government orders for pandemic (H1N1) 2009 vaccine
October 01, 2009
GlaxoSmithKline applauds compassion, competence, passion and perseverance in North Carolina’s child advocates
October 01, 2009
Avodart (dutasteride) Regulatory Update
September 30, 2009
Pandemic (H1N1) 2009 Influenza Update: GSK’s H1N1 ‘Pandemrix’ vaccine receives European Commission Approval
September 29, 2009
GlaxoSmithKline Update on FDA Review of Cervarix
September 28, 2009
GSK provides update on regulatory filings for Zunrisa/Rezonic
September 25, 2009
Pandemic (H1N1) 2009 Influenza Update: GSK’s H1N1 ‘Pandemrix’ vaccine receives positive opinion from European Regulators
September 22, 2009
GlaxoSmithKline named a 2009 100 Best Company By Working Mother Magazine
September 22, 2009
GlaxoSmithKline Receives Perfect Score on Corporate Equality Index
September 21, 2009
GSK limits medical education funding to independent programs with highest impact on patient care
September 17, 2009
Positive phase IIb results for GSK1838262 (XP13512) reported for neuropathic pain associated with post-herpetic neuralgia
September 16, 2009
GSK makes it easier for unemployed, uninsured to get free medicines
September 14, 2009
Pandemic (H1N1) 2009 Influenza Update: Initial results from first clinical trial of GSK’s H1N1 adjuvanted vaccine
September 10, 2009
GSK named to AARP list of 2009 Best Employers for Workers Over 50
September 09, 2009
FDA Advisory Committee makes favorable recommendation for Cervarix, GlaxoSmithKline’s candidate cervical cancer vaccine
September 08, 2009
New gel technology reaches hidden areas of the mouth
September 02, 2009
FDA states consumers should continue to use alli
August 25, 2009
GSK advisory: Warehouse theft
August 19, 2009
FDA approves GSK's HIB vaccine, Hiberix®
August 17, 2009
GlaxoSmithKline and Genmab announce results from a study of Arzerra in rituximab refractory follicular NHL
August 17, 2009
GSK and Brazil’s Fiocruz form partnership for new R&D effort and increased vaccine access
August 14, 2009
Pandemic (H1N1) 2009 influenza update
August 04, 2009
GlaxoSmithKline update: Government orders for pandemic (H1N1) 2009 vaccine
July 29, 2009
GlaxoSmithKline and Genmab announce top-line results for ofatumumab in rheumatoid arthritis
July 29, 2009
Regulatory update: mepolizumab for the treatment of hypereosinophilic syndrome (HES)
July 27, 2009
Amgen to collaborate with GSK to commercialize denosumab in Europe for postmenopausal osteoporosis (PMO)
July 22, 2009
GlaxoSmithKline completes acquisition of Stiefel
July 22, 2009
Results announcement for the second quarter 2009
July 22, 2009
Pandemic (H1N1) 2009 Influenza Update
July 21, 2009
GSK and Enigma Diagnostics announce commercial partnership to develop point-of-care influenza diagnostics
July 20, 2009
GlaxoSmithKline, Morehead offer "Science in the Summer"
July 08, 2009
Alnylam joins GSK in donating intellectual property to patent pool for neglected tropical diseases
July 07, 2009
Landmark study for GSK’s cervical cancer vaccine published in The Lancet
July 02, 2009
GSK further extends its product portfolio in the Middle East and North Africa
June 23, 2009
Regulatory update for REZONIC™ (casopitant mesylate)
June 16, 2009
FDA extends review of Arzerra™ (ofatumumab)
June 15, 2009
GSK announces a strategic alliance with Dr. Reddy’s to further accelerate sales growth in emerging markets
June 12, 2009
GlaxoSmithKline update: A (H1N1) influenza
June 09, 2009
GSK and Shenzhen Neptunus create new alliance to develop and manufacture influenza vaccines in China
June 03, 2009
GSK donates $100,000 to support breast health outreach
June 02, 2009
GSK and Concert Pharmaceuticals form alliance to develop novel deuterium-modified drugs
June 01, 2009
GSK’s Pazopanib significantly delayed tumor progression in patients with advanced kidney cancer
June 01, 2009
FDA approves Lamictal®XR™; an extended-release once-daily, new generation treatment for epilepsy
May 29, 2009
FDA advisory panel makes favorable recommendation for ARZERRA (ofatumumab)
May 15, 2009
GlaxoSmithKline update: A (H1N1) influenza vaccine development
May 13, 2009
FDA Advisory Committee Meeting for GSK’s Rezonic® Cancelled
May 13, 2009
Research findings on nine GlaxoSmithKline cancer compounds to be presented at ASCO 2009
May 12, 2009
GSK extends strategic collaboration with Aspen
May 11, 2009
FDA approves Lamictal® ODT™ Orally Disintegrating Tablets
May 08, 2009
New data for GlaxoSmithKline’s vaccine, Cervarix®, presented at IPV Conference
May 06, 2009
GlaxoSmithKline to divest US rights for Wellbutrin XL® to Biovail for $510 million
May 01, 2009
GlaxoSmithKline update: influenza A (H1N1)
April 27, 2009
Large, long-term study shows dutasteride reduced prostate cancer risk in men at increased risk of the disease
April 27, 2009
Emergence of a new H1N1 influenza A strain (swine influenza)
April 27, 2009
Phase II results for GSK1838262 (XP13512) reported for neuropathic pain associated with diabetic peripheral neuropathy
April 20, 2009
GlaxoSmithKline and Stiefel to create new world-leading specialist dermatology business
April 16, 2009
GlaxoSmithKline and Pfizer announce innovative agreement to create a new world-leading, specialist HIV company
April 09, 2009
Diabetes Ten City Challenge reduces health care costs and improves patient health
April 08, 2009
Heartburn sufferers find lasting relief with TUMS® dual action
April 01, 2009
GSK submits Tyverb®/Tykerb® (lapatinib) for first-line treatment of metastatic breast cancer in Europe, US
March 31, 2009
Federal cigarette tax increase and current economy will change smoker’s habits
March 30, 2009
Cervarix® U.S. regulatory update
March 25, 2009
GlaxoSmithKline global collaboration identifies two new genes for COPD
March 24, 2009
GSK publishes 2008 Corporate Responsibility Report
March 19, 2009
GlaxoSmithKline announces sale of shares in Quest Diagnostics Inc.
March 19, 2009
GSK sponsored prescription savings program, Together Rx Access, expands eligibility criteria
March 17, 2009
GlaxoSmithKline awards ten healthcare nonprofits with $40,000 each in funding
March 12, 2009
Wynonna Judd and alli to host private concert
March 11, 2009
Prasco selected as GSK’s generics marketing and distribution agent
March 10, 2009
GSK Consumer Healthcare helps to bridge oral care gap in Appalachia
March 04, 2009
GlaxoSmithKline submits European marketing authorisation application for Pazopanib in advanced kidney cancer
March 02, 2009
Ample supplies of Relenza available as flu season peaks
February 25, 2009
Wynonna Judd and alli hit the road for a healthier America
February 17, 2009
GSK initiates phase III programme for novel type 2 diabetes medication, Syncria® (albiglutide)
February 06, 2009
GlaxoSmithKline and Idenix Pharmaceuticals sign worldwide license agreement for IDX899, a novel NNRTI for the treatment of HIV
February 05, 2009
GlaxoSmithKline and Genmab seek European marketing authorisation of Arzerra™ (ofatumumab) in advanced stage blood cancer
February 05, 2009
Results announcement for the fourth quarter 2008
February 04, 2009
GSK and Theravance announce positive phase 2b results for once-daily fluticasone furoate in the treatment of asthma
February 02, 2009
GlaxoSmithKline plc, announces board changes
January 30, 2009
GlaxoSmithKline and Genmab submit Arzerra (Ofatumumab) application to FDA for the treatment of advanced stage blood cancer
January 30, 2009
Deirdre Connelly to join GSK as President, North American Pharmaceuticals
January 29, 2009
GSK announces charges for legal matters
January 29, 2009
The UK Government signs influenza pandemic contract with GlaxoSmithKline for Relenza®
January 19, 2009
GlaxoSmithKline awards ten area healthcare nonprofits with $40,000 each in funding
January 09, 2009
GSK and Xenoport resubmit new drug application for Solzira™ in restless legs syndrome
January 07, 2009
Wynonna Judd reveals her alli®, her story for finding a healthier lifestyle
December 23, 2008
Cytokinetics retains development and commercialization rights to ispinesib and SB-743921
December 23, 2008
GlaxoSmithKline and Archemix form strategic alliance to develop aptamers to treat inflammatory diseases
December 22, 2008
GlaxoSmithKline to cease providing corporate political contributions
December 22, 2008
GSK and Theravance announce positive phase 2b results for LABA `444 in the treatment of COPD in the Horizon Development Programme
December 22, 2008
GSK to acquire BMS Pakistan
December 19, 2008
GSK ready to supply RELENZA to meet new CDC interim recommendations this flu season
December 18, 2008
GSK initiates phase lll programme for novel cardiovascular medication, darapladib
December 17, 2008
GlaxoSmithKline and Dynavax announce worldwide strategic alliance
December 08, 2008
Arzerra™ (ofatumumab) demonstrates high response rates in patients with fludarabine refractory chronic lymphocytic leukemia (CLL)
December 08, 2008
New research may encourage smokers to jump-start their new year's resolution to quit smoking
December 08, 2008
FDA aproves GlaxoSmithKline Tetanus, Diptheria, Whooping cough vaccine, Boostrix®, for adults
December 08, 2008
GlaxoSmithKline extends tender offer for Genelabs Technologies, Inc.
December 08, 2008
Two new studies in the New England Journal of Medicine show malaria vaccine candidate advancing in Africa
December 06, 2008
Retigabine significantly reduces the number of seizures in adults with inadequately controlled partial-onset epilepsy
December 05, 2008
GSK analysis shows Advair is a safe and effective medicine for controlling asthma
December 04, 2008
GlaxoSmithKline and The Carter Center reaffirm commitment to global public health with expansion of LF program
December 03, 2008
GSK announces waiver of a condition to the tender offer for Genelabs Technologies
December 02, 2008
GSK and Theravance announce positive phase 2b results for LABA, `444 in the Horizon Asthma Development programme
November 20, 2008
FDA approves Promacta® (eltrombopag), the first oral medication to increase platelet production for people with serious blood disorder
November 18, 2008
Study published in archives of surgery demonstrated benefit of ENTEREG® (alvimopan) in postoperative ileus
November 17, 2008
Smokers drink almost twice as much coffee as nonsmokers, but unaware of impact of caffeine intake when quitting, new survey finds
November 14, 2008
New data shows Lovaza® improves multiple lipid parameters in patients with mixed dyslipidemia beyond effect of statin alone
November 12, 2008
GSK statement on Avandia study approach presented at American Heart Association Scientific Sessions 2008
November 10, 2008
New stop smoking aid offers unique teeth whitening benefit
November 10, 2008
GSK and Xenoport announce plans to withdraw and resubmit new drug application requesting approval of Solzira™ for restless legs syndrome
October 31, 2008
GSK believes there is no liver safety issue with Avandia; responds to Public Citizen petition
October 29, 2008
GlaxoSmithKline to acquire Genelabs Technologies to increase focus on novel small molecule therapies for Hepatitis C
October 29, 2008
Study found that long term use of Advair Diskus 250/50 did not adversely affect bone loss in patients with COPD
October 28, 2008
New research shows many patients with persistent cough and sputum actually had airway obstruction consistent with COPD
October 23, 2008
GlaxoSmithKline and AFFiRiS sign an exclusive licence and option agreement for therapeutic Alzheimer’s disease candidate vaccines
October 22, 2008
Results announcement for the third quarter 2008
October 21, 2008
GlaxoSmithKline to acquire the leading dry mouth brand, Biotene
October 15, 2008
GSK’s Emerging Markets strategy advances with acquisition in Egypt
October 07, 2008
FDA hearing on kids’ cold medicines spells greater confusion for parents
September 23, 2008
GlaxoSmithKline named a 2008 100 Best Company By Working Mother Magazine
September 22, 2008
alli™ partners with Breast Cancer Network of Strength™ to support women challenged by breast cancer, weight loss or both
September 19, 2008
GSK Update On FDA Review Of PROMACTA (Eltrombopag)
September 18, 2008
New brain imaging shows the effects of withdrawal on smokers trying to quit and how treatment helps
September 16, 2008
New data for GlaxoSmithKline’s pre-pandemic H5N1 influenza vaccine, Prepandrix™, show administration flexibility for pandemic planning
September 16, 2008
GSK and Xenoport announce submission of new drug application requesting FDA approval of Solzira™ for Restless Legs Syndrome
September 15, 2008
Pazopanib shows encouraging activity in several tumour types, including soft tissue sarcoma and ovarian cancer
September 14, 2008
Tyverb® demonstrates encouraging results in Phase II study in advanced head and neck cancer
September 12, 2008
ESMO 2008 - GlaxoSmithKline to present encouraging new data supporting late stage development programme
September 10, 2008
GlaxoSmithKline and Cellzome announce major strategic alliance
September 09, 2008
Ellen Strahlman appointed Chief Medical Officer at GlaxoSmithKline
September 08, 2008
GlaxoSmithKline plc – Directorate change
September 04, 2008
New data shows prescription omega-3 acid ethyl esters reduced the incidence of death in heart failure patients
September 03, 2008
GlaxoSmithKline Offers New Purchasing Options to Help Employers Overcome Barriers to Pandemic Stockpiling of Relenza
September 02, 2008
Os-Cal® encourages women across the country to “do the bump” to get hip about hip fracture
September 02, 2008
GlaxoSmithKline’s darapladib modifies coronary plaque composition and lowers Lp-PLA2 activity, a biomarker predictive of heart attack risk
August 28, 2008
GlaxoSmithKline and Valeant Pharmaceuticals announce worldwide collaboration agreement for retigabine
August 21, 2008
GSK to post quarterly US grants report
August 19, 2008
New study suggests increasing prescription co-payments for chronic diseases may worsen health disparities, adversely affect health
August 11, 2008
GSK begins shipments of Fluarix® and FluLaval® to U.S. customers for 2008-2009 influenza season
August 07, 2008
Head-to-head 96-week study shows EPZICOM is comparable to Truvada in efficacy and safety measures in HIV treatment-naive patients
August 07, 2008
Analysis of six clinical trials finds EPZICOM effective in treatment-naive HIV patients with both high and low baseline viral loads
August 06, 2008
Pooled-analysis of 54 clinical studies shows no increased risk of heart attack with Abacavir therapy
July 23, 2008
Results announcement for the second quarter 2008
July 23, 2008
GSK sets out new strategic priorities
July 23, 2008
GSK enters transformational agreement with Aspen to drive growth in emerging markets
July 22, 2008
Dan Troy appointed as Senior Vice President and General Counsel for GlaxoSmithKline
July 21, 2008
GlaxoSmithKline teams up with academia to develop new medicines of value
July 21, 2008
GlaxoSmithKline reaches settlement agreement with Biota
July 10, 2008
GSK supports updated PHRMA code on interactions with heatlhcare professionals
July 07, 2008
GSK receives BITC CommunityMark for global community programmes
July 01, 2008
GlaxoSmithKline to appeal judgment in Alabama Medicaid pricing suit
June 30, 2008
GlaxoSmithKline responds to FDA on Cervarix® and plans to submit final study data for approval
June 26, 2008
CDC immunization advisory committee recommends two new pediatric vaccines from Glaxosmithkline
June 25, 2008
One year later, millions are losing weight with alli
June 24, 2008
FDA approves KINRIX™ - new combination vaccine for children
June 20, 2008
GSK update on FDA review of Promacta® (eltrombopag)
June 18, 2008
Cervarix™, GSK’s cervical cancer vaccine, wins tender for UK national immunisation programme
June 18, 2008
GlaxoSmithKline responds to UK Government announcement on the PPRS
June 13, 2008
U.S. FDA approves Requip® XL™, the first and only oral once-daily non-ergot dopamine agonist for Parkinson’s disease
June 11, 2008
Avandia: Adherence Data presented at the American Diabetes Association
June 10, 2008
Results from one-year study suggest Advair provides important benefits for African American patients with asthma
June 09, 2008
Two large, independent outcomes trials offer new important safety information on cardiovascular effects of Avandia
June 06, 2008
GlaxoSmithKline acquires Sirtris Pharmaceuticals, Inc., a world leader in sirtuin research and development
June 03, 2008
Analysis showed no increased risk of hospitalization in patients when adding a LABA to ICS compared to ICS alone
June 03, 2008
GlaxoSmithKline and Boston’s Immune Disease Institute put scientists head-to-head in race for new discoveries
June 02, 2008
GlaxoSmithKline successfully completes tender offer for shares of Sirtris Pharmaceuticals
May 30, 2008
Promacta (eltrombopag) receives unanimous recommendation by FDA Advisory panel
May 29, 2008
GlaxoSmithKline announces new drug application and Phase III results for Rezonic™ / Zunrisa™ (casopitant)
May 27, 2008
Roger Scarlett-Smith named President of GlaxoSmithKline Consumer Healthcare North America
May 22, 2008
GlaxoSmithKline announces $500,000 in fellowships at Stanford Graduate School of Business
May 21, 2008
Three-year COPD study found no increase in cardiac events with Advair 500/50
May 20, 2008
Asthma uncontrolled in more than 40 percent of adults with the disease, new landmark survey shows
May 18, 2008
Advair reduces exacerbations in COPD patients with a history of exacerbations
May 18, 2008
Patients with asthma and seasonal allergies respond better to Advair® for their asthma than Singulair™
May 13, 2008
GlaxoSmithKline named a top employer for promoting healthy lifestyles
May 12, 2008
New study shows lowering co-payments can lead to lower total healthcare costs, improved overall health
May 12, 2008
Lapatinib (Tykerb®/Tyverb®) to be investigated in landmark early breast cancer trial
May 09, 2008
GSK's Ernestine Harris honored as industry "Rising Star" by Healthcare Businesswomen's Association
May 06, 2008
Don't be a snore loser - a relationship wake up call
May 02, 2008
GlaxoSmithKline commences tender offer to acquire Sirtris Pharmaceuticals
April 30, 2008
GSK announces changes to Corporate Executive Team
April 30, 2008
FDA approves ADVAIR 250/50 for reduction of exacerbations in patients with COPD
April 23, 2008
Results announcement for the first quarter 2008
April 22, 2008
GlaxoSmithKline to acquire Sirtris Pharmaceuticals, a world leader in 'Sirtuin' research and development
April 21, 2008
New TUMS QuikPak campaign offers innovative heartburn relief with a little help from The Jetsons
April 17, 2008
New study uncovers acute treatment patterns of migraine sufferers
April 15, 2008
Treximet (sumatriptan and naproxen sodium) tablets approved by FDA for acute treatment of migraine
April 01, 2008
Court rules for GlaxoSmithKline in US Patent and Trademark Office case
March 28, 2008
TUMS QuikPak 500 provides fast indigestion relief for short track racing at Martinsville Speedway
March 27, 2008
GlaxoSmithKline statement in response to D:A:D Data on Abacavir
March 27, 2008
Phase III study results show candidate combination vaccine KINRIX is immunogenic and well-tolerated
March 19, 2008
GSK charitable support valued at $564 million in 2007
March 16, 2008
GSK data suggests efficacy of Advair and Serevent is not impacted by genetic profile
March 16, 2008
Phase III study of Bosatria (mepolizumab) showed disease control with reduced corticosteroid use in hypereosinophilic syndrome
March 15, 2008
New data show Advair reduces asthma-related hospitalization and emergency department visits
March 13, 2008
20-city Zagat Survey guide spotlights outdoor destinations and offers allergy management tips
March 12, 2008
GlaxoSmithKline awards eight area healthcare nonprofits with $40,000 each in funding
March 12, 2008
Diabetes Ten City Challenge collaborative model shows improved patient health across key clinical indicators
March 10, 2008
GSK cervical cancer candidate vaccine Cervarix demonstrates long-term protection for more than six years
March 05, 2008
GlaxoSmithKline to respond to FDA request on LABAs
March 03, 2008
FDA grants priority review for Promacta (eltrombopag)
February 29, 2008
Update on GSK's malaria treatments: Dacart and Lapdap
February 28, 2008
GlaxoSmithKline comments on data concerning Epzicom from ACTG study
February 28, 2008
XenoPort and GlaxoSmithKline report positive top-line results of final pivotal trial of XP13512/GSK1838262 for restless legs syndrome
February 20, 2008
GSK receives favorable recommendation by FDA advisory committee for Rotarix [rotavirus vaccine, live, oral]
February 14, 2008
GSK launches new website to help employers lower costs and improve the health of workers
February 08, 2008
FDA extends review of NDA for Entereg (alvimopan)
February 07, 2008
Full-year results announcement 2007
February 06, 2008
GlaxoSmithKline responds to findings in ACCORD study
February 04, 2008
GlaxoSmithKline and Amira Pharmaceuticals enter global agreement for FLAP inhibitor programme
January 31, 2008
GlaxoSmithKline files pneumococcal paediatric vaccine in the EU
January 30, 2008
GlaxoSmithKline responds to letter from Senator Grassley
January 28, 2008
GlaxoSmithKline and Synta announce elesclomol granted US orphan drug designation by the FDA
January 24, 2008
GlaxoSmithKline and Medicines for Malaria Venture announce new collaboration to investigate novel antimalarial compounds
January 24, 2008
GlaxoSmithKline and TB Alliance renew tuberculosis drug discovery programme
January 24, 2008
GlaxoSmithKline appoints Lon Cardon to focus Genetics on new disease targets
January 24, 2008
GSK / MRC to identify new therapeutic targets and biomarkers from genetic association studies
January 15, 2008
XenoPort and GlaxoSmithKline report positive top-line results of second phase 3 Restless Legs Syndrome trial for XP13512/GSK1838262
January 15, 2008
Migraines affect high number of African Americans, yet this group is less likely to seek medical attention, get treatment
January 08, 2008
New study indicates decreasing prescription copayments results in increased adherence for patients with chronic diseases
January 08, 2008
GlaxoSmithKline announces online ordering of Fluarix® (influenza virus vaccine) for 2008-2009 flu season
January 03, 2008
GlaxoSmithKline and Theravance announce start of large Phase 2B ICS and LABA studies for asthma in the Horizon programme
December 20, 2007
GlaxoSmithKline files for FDA approval of Promacta/ Revolade (eltrombopag) to be the first oral platelet growth factor for rare blood disorder
December 19, 2007
GlaxoSmithKline completes acquisition of Reliant Pharmaceuticals
December 17, 2007
GlaxoSmithKline receives FDA ‘complete response’ letter for cervical cancer vaccine
December 16, 2007
GlaxoSmithKline announces data on Tykerb ® (lapatinib) plus capecitabine for the treatment of HER2-positive breast cancer brain metastases
December 13, 2007
GlaxoSmithKline presents innovative neuroscience pipeline
December 11, 2007
GlaxoSmithKline Responds to JAMA article on the ICES Thiazolidinediones and Cardiovascular Outcomes in Older Patients with Diabetes
December 10, 2007
GSK receives decision from US FDA on Requip® XL™ extended-release tablets
December 10, 2007
Long-term safety and efficacy data on Promacta™ (eltrombopag) presented at American Society of Hematology Annual Meeting
December 10, 2007
GlaxoSmithKline and OncoMed Pharmaceuticals form strategic alliance to develop cancer stem cell antibody therapeutics
December 10, 2007
GlaxoSmithKline and Galapagos enter strategic alliance to develop novel antibacterials and antivirals
December 07, 2007
GlaxoSmithKline announces appointments to the Board Of Directors
December 06, 2007
GSK’s continued commitment to fighting HIV/AIDS results in approval of new formulations of three medicines for the treatment of children
December 03, 2007
GSK response to Nature Medicine article on rosiglitazone and bone in mice
December 03, 2007
GSK statement on ADA/EASD updates to diabetes treatment guidelines with new information on the thiazolidinediones (TZDs)
November 28, 2007
GSK statement on US Food and Drug Administration Pediatric Advisory Committee recommendations regarding Salmeterol
November 26, 2007
GlaxoSmithKline obtains exclusive U.S. OTC marketing rights to MEVACOR (lovastatin) from Merkc & Co., Inc.
November 23, 2007
New data published in The Lancet show GSK's Rotarix Offers protection against the most common circulating rotavirus types
November 21, 2007
GlaxoSmithKline to acquire Reliant Pharmaceuticals
November 20, 2007
GlaxoSmithKline and Genmab initiate ofatumumab rheumatoid arthritis Phase III programme
November 14, 2007
GSK revises US labeling for Avandia
November 11, 2007
New data shows Veramyst effectively treats symptoms of perennial allergic rhinitis
November 07, 2007
Prometheus to acquire Lotronex from GlaxoSmithKline
November 02, 2007
Fabre Kramer Pharmaceuticals receives decision from FDA on gepirone ER for major depressive disorder
October 26, 2007
GlaxoSmithKline aids California fire relief efforts
October 24, 2007
Results announcement for the third quarter 2007
October 23, 2007
GlaxoSmithKline and Tolerx form worldwide collaboration for development and commercialisation of novel medication
October 18, 2007
European Medicine Agency (EMEA) confirms positive Avandia benefit risk assessment
October 17, 2007
New Lancet study: Malaria vaccine candidate has promising safety, tolerability profile in infants
October 16, 2007
New data published in neurology show once-daily Lamictal XR significantly reduced partial seizures in patients with epilepsy
October 15, 2007
GSK receives approval for Hycamtin (topotecan) capsules for the treatment of relapsed small cell lung cancer
October 12, 2007
FDA approves administration of LEXIVA with lower dose of boosting medication ritonavir
October 10, 2007
GlaxoSmithKline and Synta Pharmaceuticals announce development and commercialisation collaboration for STA-4783 in oncology
October 08, 2007
GlaxoSmithKline appoints Andrew Witty CEO designate
October 08, 2007
GlaxoSmithKline and Anacor Pharmaceuticals form alliance to develop systemic antivirals and antibiotics based on boron chemistry
September 28, 2007
GlaxoSmithKline PLC announces change to the Board of Directors
September 27, 2007
GlaxoSmithKline helps form the Serious Adverse Events Consortium
September 26, 2007
Congressional Black Caucus Foundation and GlaxoSmithKline announce supplier business initiative study results
September 25, 2007
GlaxoSmithKline named to Working Mother "100 Best Companies" list
September 21, 2007
A new interactive consumer experience highlighting successful weight loss strategies is coming to a mall near you
September 21, 2007
GSK receives decision from FDA on Lamictal XR Extended-Release Tablets
September 19, 2007
New data show that GlaxoSmithKline's Rotarix could be given with other routine infant vaccines in the U.S.
September 19, 2007
New study shows once-monthly Boniva is as clinically effective as once-weekly Fosamax at increasing bone mineral density in postmenopausal women with osteoporosis
September 18, 2007
GlaxoSmithKline awarded US Department of Defense contract to pursue novel antibacterial research program
September 13, 2007
GlaxoSmithKline increases US seasonal flu vaccine shipments
September 11, 2007
GlaxoSmithKline and Sepracor Inc. announce international alliance for commercilisation of Lunivia
September 11, 2007
GlaxoSmithKline responds to JAMA articles
September 04, 2007
Study shows combination therapy incorporating Avodart and tamsulosin provides continuous symptom improvement over two years
August 29, 2007
GSK supports emphasis on asthma control and use of quick assessment tools in new asthma treatment guidelines
August 28, 2007
FDA accepts for review complete response to approvable letter for Entereg(Alvimopan) for POI
August 28, 2007
Practicing what they preach: GSK announces employee wellness initiative
August 16, 2007
GlaxoSmithKline IMPACT Awards deadline August 28, 2007
August 14, 2007
GlaxoSmithKline's application for Rotarix is accepted for review by the FDA
August 14, 2007
GlaxoSmithKline Updates Prescribing Information for Avandia
August 10, 2007
GSK Receives Decision from FDA on Requip CR (ropinirole)
August 08, 2007
GSK receives decision from FDA on Advair 500/50 for COPD
August 07, 2007
Celebrity health and fitness dream team show heart attack survivors how to 'flex their heart muscle'
August 03, 2007
GlaxoSmithKline receives new HHS order for H5N1 bulk antigen
August 02, 2007
FDA issues second approvable letter for Trexima
July 30, 2007
GlaxoSmithKline presents Avandia data to FDA
July 30, 2007
Pharmetrics epidemiology study
July 30, 2007
FDA Advisory Panel votes 22 to 1 for Avandia to remain available to patients in the US
July 27, 2007
GlaxoSmithKline statement in diabetes care study thiazolidinediones and heart failure: a teleo-analysis [1]
July 27, 2007
GlaxoSmithKline and Targacept form alliance in therapeutics for CNS-related disorders
July 25, 2007
New head-to-head study comparing Lexiva and atazanavir show similar efficacy and lipid changes
July 25, 2007
Results announcement for the second quarter 2007
July 12, 2007
GlaxoSmithKline seeks nonprofits that provide access to healthcare for 11th annual GlaxoSmithKline IMPACT Awards
June 18, 2007
GlaxoSmithKline expects to launch up to five major new medicines for oncology in next three years
June 15, 2007
LEXIVA approved for treatment of HIV in pediatric patients
June 14, 2007
Pro football legend Troy Aikman puts a new face on migraines
June 13, 2007
GlaxoSmithKline to make unprecedented vaccine donation to WHO pandemic flu stockpile
June 13, 2007
GlaxoSmithKline's application for DTaP-IPV vaccine is accepted for review by the FDA
June 12, 2007
alli - the OTC weight loss product - on shelves nationwide later this week
June 12, 2007
FDA grants priority review for oral formulation of HYCAMTIN (topotecan) to treat relapsed small cell lung cancer
June 11, 2007
GlaxoSmithKline and Adolor update alvimopan (Entereg/Entrareg) development programme
June 11, 2007
Pivotal phase III trial showed Promacta (eltrombopag olamine) raised platelet counts and reduced bleeding
June 08, 2007
Trexima (sumatriptan/naproxen sodium) demonstrated migraine-free response across multiple attacks
June 06, 2007
Newly published data from large study support cardiovascular safety of Avandia (rosiglitazone maleate)
June 05, 2007
GlaxoSmithKline Response to New England Journal of Medicine Editorials
June 04, 2007
8-year long-term data demonstrate prolonged overall survival and length of disease remission with BEXXAR
June 01, 2007
GlaxoSmithKline honors cancer research pioneer Gianni Bonadonna with new ASCO Award And Fellowship
May 30, 2007
Data affirms Avandia (rosiglitazone maleate) cardiovascular safety profile
May 23, 2007
GlaxoSmithKline plc - results of AGM
May 22, 2007
alli debuts through the alli Experience
May 21, 2007
Cervarix is approved in Australia for females 10-45 years old
May 21, 2007
GlaxoSmithKline responds to NEJM article on Avandia
May 21, 2007
GlaxoSmithKline strongly defends its record on Avandia
May 17, 2007
Sally Field addresses members of Congress about osteoporosis during national osteoporosis awareness month
May 08, 2007
Fabre-Kramer refiles gepirone ER with the FDA for the treatment of major depressive disorder
May 02, 2007
GlaxoSmithKline supports World Health Organization efforts to strengthen global pandemic preparedness plans
May 02, 2007
Trexima (sumatriptan/naproxen sodium) demonstrated efficacy across multiple migraine attacks
May 01, 2007
FDA Advisory Committee finds substantial evidence to support Advair 500/50 in reducing COPD exacerbations
May 01, 2007
New data shows once a day Lamictal XR is effective in treating patients with partial seizures
April 30, 2007
GlaxoSmithKline and Wellcome Trust announce partnership to target drug-resistant hospital infections
April 30, 2007
New book educates Americans about losing weight without losing their mind
April 25, 2007
Results announcement for the first quarter 2007
April 12, 2007
GSK initiates repeat dosing study of its novel oral platelet growth factor, eltrombopag, in ITP
April 12, 2007
GSK announces FDA approval of Altabax (retapamulin ointment), 1%
April 09, 2007
GSK and Adolor announce preliminary results from Phase 3 safety study of Alvimopan (Entereg/Entrareg)
April 03, 2007
Once daily, extended-release ropinirole improves Parkinson's symptoms in patients not optimally controlled with levodopa
April 03, 2007
Trexima (sumatriptan/naproxen sodium) superior efficacy data published in JAMA
April 02, 2007
FDA approves accelerated dosing schedule for GSK's Twinrix
March 29, 2007
GlaxoSmithKline appoints Zhi Hong to head infectious-diseases research centre
March 29, 2007
GlaxoSmithKline submits Biologics License Application to US Food and Drug Administration for Cervarix
March 26, 2007
New study indicates nicotine patches may be safe for helping patients with coronary artery disease to quit smoking
March 23, 2007
Eight local nonprofit groups receive recognition, financial support for good work
March 22, 2007
GSK announces nationwide availability of once-a-day COREG CR for the treatment of three key cardiovascular conditions
March 20, 2007
FiberChoice plus Multivitamins issues allergy alert
March 20, 2007
GlaxoSmithKline introduces HIV education initiative for community-based AIDS service organizations
March 13, 2007
GlaxoSmithKline announces expansion of patient assistance program to include Tykerb
March 09, 2007
New JACC analysis details cardiovascular protective benefits of carvedilol in heart failure patients
March 05, 2007
New studies indicate GSK's pre-pandemic influenza vaccine can protect against different strains of H5N1
March 01, 2007
Study published in New England Journal of Medicine: Vaccine 95.5% effective against neglected hepatitis E
February 27, 2007
Survey shows discomfort with existing nasal sprays causes allergic rhinitis patients to discontinue treatment
February 27, 2007
New data showed fluticasone furoate nasal spray effectively treated nasal symptoms of allergic rhinitis
February 27, 2007
Studies showed fluticasone furoate nasal spray was well-tolerated and effective in treating allergic rhinitis in pediatric patients
February 26, 2007
GSK initiates first global Phase III study of Tykerb (lapatinib) in head and neck cancer
February 22, 2007
GlaxoSmithKline and NBPTS announce $1 million endowment to strengthen science education in America's classrooms
February 21, 2007
Results from landmark study suggest that Advair 500/50 provides important benefits for patients with COPD
February 20, 2007
GlaxoSmithKline acquires exclusive rights to over-the-counter orlistat for markets outside the US from Roche Group
February 20, 2007
OFT market study into the Pharmaceutical Price Regulation Scheme
February 16, 2007
GlaxoSmithKline successfully completes tender offer for shares of Praecis Pharmaceuticals
February 16, 2007
GlaxoSmithKline Diseases of the Developing World ad campaign receives industry award
February 13, 2007
WHO awards prequalification status to GSK rotavirus vaccine
February 13, 2007
GlaxoSmithKline and Human Genome Sciences announce initiation of Phase 3 clinical trial of Lymphostat-B in systemic lupus erythematosus
February 13, 2007
GlaxoSmithKline offers new tools to help patients get free medicines
February 12, 2007
GlaxoSmithKline plc announces change to the Board of Directors
February 09, 2007
GlaxoSmithKline commends $1.5 billion advance market commitment for pneumococcal vaccines
February 08, 2007
GlaxoSmithKline and Fabre-Kramer Pharmaceuticals enter global agreement for new treatment of major depressive disorder
February 08, 2007
GlaxoSmithKline and XenoPort announce agreement on late-stage compound for RLS and neuropathic pain
February 08, 2007
Full-year results announcement 2006
February 07, 2007
GlaxoSmithKline accepts shares in tender offer for shares of Praecis Pharmaceuticals and commences subsequent offering period
February 07, 2007
FDA approves alli (orlistat 60 mg capsules) over-the-counter
February 02, 2007
GlaxoSmithKline receives approvable letter for new indications for Arixtra (fondaparinux sodium) injection
February 02, 2007
Valtrex (valacyclovir) - US patent litigation update
January 29, 2007
GlaxoSmithKline files its new pre-pandemic influenza vaccine in Europe
January 18, 2007
GlaxoSmithKline initiates head-to-head study of cervical cancer vaccines
January 09, 2007
GlaxoSmithKline commences tender offer to acquire Praecis Pharmaceuticals
To download PDF files you will need Adobe Reader. If you do not have it installed, it is available free from the Adobe website. PDF links on this site open in a new window.
For audio-visual content you can use either Windows Media Player or Real Player, which can be installed free from their respective websites.
